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Construction and Validation of the Fatigue Impact and Severity Self-Assessment for
Youth and Young Adults with Cerebral Palsy
Abstract
Purpose: The Fatigue Impact and Severity Self-Assessment (FISSA) was created to
assess the impact, severity and self-management of fatigue for individuals with
cerebral palsy (CP) aged 14-31.
Methods Used: Items were generated from a review of measures and interviews
with individuals with CP. Focus groups with healthcare professionals were used for
item reduction. A mailed survey was conducted (n=163/367) to assess the factor
structure, known-groups validity and test-retest reliability.
Results Obtained: The final measure contained 31-items in two factors and
discriminated between individuals expected to have different levels of fatigue.
Individuals with more functional abilities reported less fatigue (p< 0.002) and those
with higher pain reported higher fatigue (p< 0.001). The FISSA was shown to have
adequate test-retest reliability, ICC(3,1)=0.74 (95% CI 0.53-0.87).
Conclusions Reached: The FISSA valid and reliable for individuals with CP. It allows
for identification of the activities that may be compromised by fatigue to enhance
collaborative goal setting and intervention planning.
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1. Introduction
Fatigue has been identified as one of the top three cerebral palsy (CP)-related
impairments in adulthood that can affect activities of daily life [1]. Approximately
20% of physicians reported a noticeable functional deterioration in the adults with
CP they treat [1]; some self-reported causes of such deterioration include spasticity,
fatigue, pain and lack of physical training [2, 3]. Fatigue has been shown to be more
prevalent in adults with CP compared to the general population [4]. A 20%
prevalence of fatigue in a sample of adults with CP has been reported and notably,
41% of those individuals were classified as severely fatigued [5]. Individuals who
reported severe fatigue were 2.3 times more likely to report concurrent chronic
pain and 3.4 times more likely to report concurrent depressive symptoms [5]. In
addition, there are reports that fatigue may play a role in physiological burnout
experienced by adults with CP. Deficits in muscle function, combined with the
natural history of CP and the development of secondary conditions (such as fatigue)
during growth and maturation, have been hypothesized to lead to functional
deterioration and early loss of mobility [6, 7], the specific role fatigue may play in
this cycle remains unknown. In a personal reflection, Jones [3] discussed her
experience of aging with CP and discussed the need to better understand the
prevention and management of secondary conditions such as fatigue.
There are numerous published scales available to measure fatigue; however,
none have been validated for use in a population of individuals with CP. The
purpose of this study was to create and validate a new measure of fatigue, the
Fatigue Impact and Severity Self-Assessment (FISSA), to gain a better understanding

of fatigue experienced and to enhance self-management of fatigue for individuals
with CP.
2. Methods
Phase 1 – Initial item generation
As part of a larger study, a search was conducted in the CINAHL and EMBASE
databases for articles that assessed the psychometric properties of published fatigue
scales [8]. Fatigue scales identified in the search were then reviewed and items were
identified based on relationships to themes in the existing literature. Secondly, items
were generated based on the themes discussed by individuals with CP in a
phenomenological inquiry (n=10) described elsewhere [9]. The collated items were
rephrased to enhance relevance and to simplify or standardized the language and
formatted into a new questionnaire.
Phase 2 – Item reduction and refinement
Two focus groups were then held with healthcare providers at children’s
treatment centres in Ontario, Canada. Healthcare professionals who normally treat
individuals with CP helped reduce the number of items to a small, relevant subset of
questions [8]. Involving expert clinicians in the refinement of this measure enhances
the content validity, which strengthens the clinical inferences that may be drawn
from the questionnaire [10].
A modified nominal group technique [11] was used to reduce the items from
the scale, and to add items that that were overlooked in the previous stages of item
generation. The use of both activities (reduction and addition of new items) ensured
balance between preserving a high level of content validity, creating a feasible

questionnaire, limiting respondent burden and incorporating the perspectives of
service providers who work with individuals with CP.
Phase 3 - Feasibility testing
Ten questionnaires were distributed to individuals with CP between the ages
of 14 and18 years from children’s treatment centres in Ontario, Canada; who were
classified as level I or II on the Communication Function Classification System
(CFCS) [12] and as levels I to IV on the Expanded and Revised Version of the Gross
Motor Function Classification System (GMFCS-ER) [13]. Participants were asked to
read the FISSA and complete a feasibility questionnaire to ensure that the items
were comprehensible, unambiguous and easy to respond to. This step was
considered a separate assessment of the content validity of the scale.
Phase 4 – Psychometric assessment
A large survey mailing was used to assess the psychometric properties,
specifically the factor structure, known-groups validity, internal consistency and
test-retest reliability, of the FISSA. A total of 367 youth and young adults with CP
were contacted as potential participants for the study from participating children’s
rehabilitation centres in Ontario, Canada, previous research studies, existing
facebook groups for individuals with CP and through the Ontario Federation for
Cerebral Palsy website and newsletter. Due to the diverse recruitment methods,
individuals of all functional ability levels elected to participate. Study eligibility
criteria included individuals aged 14 to 31 years of age, English speaking and the
ability to complete the questionnaire with some degree of independence. Returned
surveys that were completed entirely by parental proxy were excluded from the

study. In addition to the FISSA, a self-report version of the GMFCS-ER [13] was used
to collect information on the participants’ level of functional ability. Other measures
included a simple demographic questionnaire used to obtain self-reported
distribution of involvement, age and sex and a pain questionnaire to collect
information on prevalence, severity, impact and location of pain [14]. The final page
of the survey booklet asked for information regarding the amount of assistance
required to complete the survey.
The study followed a modified Dillman method [15]. All potential
participants initially received a full survey package (either a hard copy or a link to
an online version of the survey materials). A reminder letter was mailed (or
emailed) to each potential participant approximately two weeks following the initial
mailing. All individuals who had not returned or completed the survey two weeks
after the reminder letters were sent received a second full questionnaire package or
an email containing the original link. To assess the test-retest reliability of the FISSA
and pain questionnaires, a small subset of the sample were asked to complete these
portions of the survey a second time approximately two weeks after their initial
response. All phases of this study received ethical approval from the ethics review
boards at Western University, McMaster University and specific clinical sites as
appropriate. Each individual participant provided written informed consent, or in
case of the survey, completion implied consent, to participate in this study.
An exploratory factor analysis was conducted using principal components
analysis on the final data set obtained from the FISSA. Prior to conducting the factor
analysis, the data were screened for suitability using inspection of the magnitude of

correlations among items [16], the Kaiser-Meyer-Olkin measure of sampling
adequacy and Bartlett’s test of sphericity. Cattell’s Scree test and parallel analysis
were used to determine the number of factors extracted and retained for the
remainder of the analysis. The remaining factors were then rotated to better
understand the meaning of each factor using the direct oblimin approach as it was
hypothesized that the factors would be related. A final model was then created to
explain the underlying structure of the questionnaire and to understand how the
factors were acting in the scale.
The known groups validity of the FISSA was examined by investigating the
difference in fatigue score by GMFCS level and between high and low pain
(represented by both severity and impact of pain). GMFCS levels were grouped
together to increase the subgroup sample size and consisted of individuals who selfclassified as level I separately, levels II and III were grouped together and levels IV
and V formed the third group. The Kruskal-Wallis statistic was used to compare the
difference in fatigue between groups of GMFCS levels. A median split was applied to
the pain severity and impact data and a Mann-Whitney U was used to assess the
difference in fatigue by pain level. Internal consistency of the FISSA was assessed
using Cronbach’s alpha. Test-retest reliability of the FISSA and pain questionnaire
were analysed using an intraclass correlation, specifically the ICC(3,1) model was
used [17].
3. Results
Phase 1 – Initial item generation

The initial draft of the scale comprised 50 items. Forty-four items were
selected from 9 different fatigue scales identified in the review [8]. Furthermore, the
author created 6 additional items to represent concepts discussed in the interviews
conducted with youth and young adults with CP in the study by Brunton and
Bartlett [9].
Phase 2 – Item reduction and refinement
A total of 11 healthcare professionals (5 Physical Therapists, 3 Occupational
Therapists, 1 Recreation Therapist/Kinesiologist, 1 Nurse and 1 Physiatrist)
participated in one of two focus groups. The initial focus group resulted in removal
of 11 items, rephrasing the remaining items for consistency and clarity, and the
addition of 4 items to the questionnaire. The second focus group resulted in removal
of 3 items and the addition of 4 items. The participants in the second focus group
informed the draft definition of fatigue as follows ‘Please answer the following
questions about your experience with fatigue. For the purposes of this questionnaire
we would like you to think about fatigue in terms of: physical tiredness, muscle
soreness, exhaustion of your muscles and body, or any related feeling. When
answering the questions, please try to focus on fatigue as it is defined above and not
pain you may experience that is different from muscle soreness’.
Response options were then set to a 1 to 5 Likert scale, allowing for a neutral
option and anchors provided on each number from ‘Completely Disagree’ to
‘Completely Agree’. This scale was chosen to align with the scaling requirements for
a reliable discriminative measure [18, 19]. Several questions related to the severity
of fatigue were given a variety of scaling options as related to individual questions

as appropriate. Specifically, 5 questions regarding severity and variability of fatigue
were given separate scaling options. Questions asking about level of fatigue on the
most and least fatiguing days and on the average day were scaled to have the labels
reflect “No Fatigue” to “Severe Fatigue” with the middle label representing
“Moderate Fatigue”. Similarly question 16 “On average, how much of the day do you
feel fatigued?” was scaled to divide the day into quarters and provide a no fatigue
option. Question 17 “For how many days last week did you feel fatigued at least part
of the day?” was scaled according to the possible 7 days in a week. It was felt that
these changes were required to accurately capture meaningful information
regarding fatigue severity and variability that could not be captured in with the
scoring system used in the rest of the measure. Finally, a timeframe of 7 days was
added to the questionnaire to orient users to consider the same timeframe when
completing the questionnaire.
Phase 3 - Feasibility testing
Five feasibility questionnaires were returned completed; two individuals
withdrew from the project - one due to the time required to complete the
questionnaire and one due to feeling overwhelmed by the impact of fatigue on their
daily life as a result of reading the questionnaire. The remaining three
questionnaires were not returned for unknown reasons. Three participants felt that
the FISSA was easy or not too difficult to understand, with one participant needing
help understanding the meaning of some words. The final participant found the
impact section of the questionnaire confusing and felt it was only relevant to
individuals who were ambulatory. Four of the five participants indicated that the

response options were appropriate given the questions that were being asked and
on consideration of this feedback, no changes were made to the FISSA [8].
Phase 4 – Psychometric assessment
Of the 367 individuals contacted, 163 questionnaires were returned over the
course of the study, for a response rate of 44.4%. A final convenience sample of 130
youth and young adults with CP participated in the study by returning a
questionnaire (completed at least semi-independently). Figure 1 provides a detailed
breakdown of the returned questionnaires. Table 1 contains the participant
characteristics and demographic information of the 130 participants.
During the data screening for adequacy for factor analysis the internal
consistency of the 32 items together was 0.95. The non-parametric Spearman’s Rho
correlations did not reveal any correlations above 0.9 and 62% of the correlations
were above 0.3, the Kaiser-Meyer-Olkin measure of sampling adequacy was
demonstrated to be 0.90, which is considered to be excellent [20], and Bartlett’s test
of sphericity was found to be significant (p< .001) all indicating that the data set was
appropriate for factor analysis. Based on Cattell’s Scree plot and parallel analysis,
two factors (Impact of Fatigue on Daily Living and Management and Activity
Modification) were retained in the factor structure of the FISSA and together they
explained 48.7% of the variance. The Impact factor explained 42.5% of the variance
and the Management and Modification Factor explained an additional 6.2% of the
variance in fatigue scores. Item loadings found to be 0.4 or greater were considered
significant [21]. In total 17 items loaded on the first factor (Impact of Fatigue on
Daily Living) and 15 items loaded on the second factor (Management and Activity

Modification). One item (Fatigue interferes with my participation in social activities)
loaded moderately on both factors; however, it is considered to be part of the first
factor given its slightly larger loading. Finally one item (Fatigue interferes with my
ability to control my mood) did not load sufficiently on either factor and was
removed from the scale, resulting in a final 31-item version of the FISSA (Appendix
A). Refer to Table 2 for the individual factor loadings.
Table 3 contains the descriptive information of the FISSA score by grouped
GMFCS level, and low or high pain level. Individuals classified as GMFCS level I
experienced significantly less fatigue than individuals classified in any other GMFCS
level (II-V) (p< 0.001). Individuals classified as GMFCS level IV or V did not
experience significantly more fatigue when compared to individuals classified as
GMFCS level II or III regardless of whether the total score (p= 0.063) or the
individual factor scores were assessed (Impact p=0.069; Management p=1.0).
Individuals with higher pain (both impact and severity) reported higher total FISSA
scores and higher individual factor scores (p< 0.001).
The Cronbach’s alpha for the 31-item FISSA was 0.95. The average test-retest
interval in this study was 36 days (range 13 to 87 days). A total of 31 individuals
returned their test-retest package completed. The FISSA as a whole demonstrated
moderate reliability with an ICC(3,1) = 0.75 (95% CI 0.54-0.87). The pain
questionnaire demonstrated an ICC(3,1) = 0.73 (95% CI 0.50-0.86) for the impact
component and an ICC(3,1) = 0.78 (95% CI 0.59-0.89) for the severity component.
4. Discussion

A new fatigue scale, the FISSA, was created using a variety of methods to
ensure relevance to the users of the scale: youth and young adults with CP and their
healthcare providers. A review of fatigue measures in the context of knowledge of
the clinical course of CP allowed for inclusion of items known to be related to fatigue
in CP. The interviews described in the study by Brunton and Bartlett [9] provided a
client-centered approach to item generation and selection to enhance the
applicability of the questionnaire to individuals with CP. The healthcare providers
who participated in focus groups offered an expertise-based method of reducing
and adding items to the scale to balance respondent burden while retaining a
complete and relevant set of items. The FISSA was then pilot tested in a sample of
youth and young adults with CP to ensure the questions were easily understood and
completed by potential users of the scale. One participant posed the question ‘Why
do my muscles ache when I am fatigued?’ to her doctor as a result of reading and
completing the questionnaire, providing evidence that the FISSA is prompting
individuals to think about fatigue and the consequences of activity, which may
contribute to the development of self-awareness [8].
An exploratory factor analysis and a known groups validation approach
were used to provide evidence of content and construct validity of the FISSA as
there is currently no accepted measure available to provide information about
fatigue in individuals with CP. The FISSA demonstrated a related 2-factor solution
that explained 49% of the variance and was able to discriminate between groups
expected to experience more fatigue (individuals classified as having more
functional impairment according to the GMFCS and individuals experiencing a high

degree of pain, both in terms of severity and impact). Finally, the FISSA was shown
to be reliable with a high degree of internal consistency and a moderate correlation
coefficient over a period of time where no change was expected.
Many individuals (regardless of GMFCS level) live with fatigue as a
consequence of daily activities [22] and there are limited strategies available to
these individuals to effectively manage their fatigue. There is a great need to
understand how fatigue is impacting a client’s life and the ability to accomplish
activities of daily living [23]. The FISSA was created with this goal in mind: to assist
with identifying individuals who are experiencing fatigue related to CP and as a
method of fostering a clinical discussion between clinicians and their clients about
fatigue and possible management strategies. The FISSA provides a preliminary
description of activities that fatigue interferes with, an overview of the severity of
fatigue experienced by the individual and a report on the management strategies
that an individual may or may not have tried to effectively limit or manage their
fatigue. Early identification of fatigue and the activities that are most affected may
assist with intervention selection to interrupt the cycle of deconditioning described
in individuals with CP [7]. The progression of the activity limitations in CP as a
result of fatigue are thought to be linked to functional decline that can affect
independence in adult life [7]. Once fatigue is identified, strategies and adaptions to
increase fatigue management in specific areas may be more easily conceivable and
available to these individuals. This self-assessment can be used on an individual
basis to streamline a clinical conversation to the salient fatigue-related issues. For
example, fatigue experienced in community settings that require long distance

ambulation or activities that are of a long duration might be managed and mitigated
by initiating discussions on the use of powered mobility. The goal would be to
highlight the individual’s ability to increase their engagement in the activity while
recognizing that fatigue may be a limiting factor. Another example would be
discussing the opportunities for rest or napping during a typical day or week to
manage fatigue that accumulates or changes based on daily or weekly tasks. The
FISSA may help clinicians effectively discuss possible solutions and strategies to
limit or manage the impact of fatigue that is specific to the individual (i.e. daily or
weekly patterns of fatigue, specific challenges or activities) while being mindful of
limited time and resources in the clinical setting.
Limitations
Several authors have suggested a ratio of between five to ten participants
per item when determining sample size adequacy for factor analysis. This is a
limitation in this study as the ratio of participants to items was 4:1. However, these
guidelines have been challenged [24] and it was found that changes to the
participant to item ratio made little difference in the stability of the factor solution
when parallel analysis was used as the primary extraction method. In addition, it
has been argued that factors that contain four or more loadings of 0.60 or higher are
reliably extracted regardless of the sample size [25]. In the case of the FISSA, both
factors readily met this criterion. The FISSA was unable to discriminate individuals
classified as GMFCS Level II and III from those classified as GMFCS Level IV and V,
this could have been due to the relatively small subgroup sample sizes and should
be investigated with a larger study in the future. Presently the FISSA has only been

validated for use as a discriminative measure. Future validation efforts are needed
prior to using the FISSA as a predictive or evaluative measure. The authors of this
study plan to continue to evaluate the validity of the FISSA in terms of it’s utility as a
predictive and/or evaluative measure. Similarly, ongoing use of the FISSA in both
clinical practice and research will allow for evolution of the measure through
increased refinement of items and through additional testing of the factor structure
and subscale profiles. Finally, more research is needed regarding the effectiveness
of fatigue management strategies used by individuals with CP.
Conclusion
The FISSA represents a valid and reliable tool that can be used to identify
individuals who have a significant impact of fatigue on their lives. We hope that
clinicians will use the FISSA to initiate conversations about the functional
restrictions individuals are experiencing as a result of fatigue and use the measure
as a starting point for discussion about possible management strategies. Jones [3]
recognized the need to identify and collaborate on interventions to address
functional problems; the FISSA can facilitate this collaboration. Clinicians can
examine the responses to individual items of the FISSA as a method of identifying
the specific areas of the individual’s life that fatigue is impacting most, especially
given the highly individualized presentation of CP. Ideally, the FISSA will then be
used to facilitate collaborative goal setting and future intervention planning
between clinicians and their clients and families.
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Appendix A

Fatigue Impact and Severity Self-Assessment (FISSA)
Please answer the following questions about your experience with fatigue. For the
purposes of this questionnaire we would like you to think about fatigue in terms of:
• physical tiredness
• muscle soreness
• exhaustion of your muscles and body
• or any related feeling
When answering the questions, please try to focus on fatigue as it is defined above and
not pain you may experience that is different from muscle soreness.
Impact Scale
Completely
Disagree
1

Somewhat
Disagree
2

Neither Agree
nor Disagree
3

Somewhat
Agree
4

Completely
Agree
5

Using the scale above and thinking about a typical week (7 days), to what extent do you
agree with the following statements?
Fatigue interferes with …
1. my general everyday activities

1

2

3

4

5

2. my ability to move around indoors

1

2

3

4

5

3. my ability to do things on my own

1

2

3

4

5

4. my ability to move around in my community

1

2

3

4

5

5. my ability to get outside of my house

1

2

3

4

5

6. my ability to finish things

1

2

3

4

5

7. my participation in social activities

1

2

3

4

5

8. my ability to start things

1

2

3

4

5

9. my ability to take care of myself (examples: dressing, eating, bathing,
brushing my teeth/hair, toileting etc.)

1

2

3

4

5

In addition,
10. I use adaptive equipment to manage my fatigue (examples: a walker,
manual wheelchair, power wheelchair etc.)

1

2

3

4

5

11. I have had to reduce my work responsibilities outside of my home
because of fatigue (examples: school work, job-related work,
volunteering etc.)

1

2

3

4

5

12. I have had to reduce my responsibilities at home because of fatigue

1

2

3

4

5
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Appendix A
Using the scale given with each question, please think about the last seven (7) days
and answer the following statements or questions.
13. Rate your level of fatigue on the day within the last week that you felt the most
fatigued:
No Fatigue

Moderate Fatigue

1

2

3

Severe Fatigue
4

5

14. Rate your level of fatigue on the day within the last week that you felt the least
fatigued:
No Fatigue

Moderate Fatigue

1

2

3

Severe Fatigue
4

5

15. Rate your average level of fatigue for the past week:
No Fatigue

Moderate Fatigue

1

2

3

Severe Fatigue
4

5

16. On average, how much of the day do you feel fatigued?
None

A Quarter
of the Day

1

Half the Day

2

Three Quarters
of the Day

3

4

All Day
5

17. For how many days last week did you feel fatigued at least part of the day?
1

2

3

4

5

6
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Management and Activity Modification Scale
Using the scale below and thinking about a typical week (7 days), to what extent do you
agree with the following statements?
Completely
Disagree
1

Somewhat
Disagree
2

Neither Agree
nor Disagree
3

Somewhat
Agree
4

Completely
Agree
5

Fatigue interferes with …
18. my enjoyment of life

1

2

3

4

5

19. my leisure and recreational activities

1

2

3

4

5

20. the length of time I can be physically active

1

2

3

4

5

21. my balance and coordination

1

2

3

4

5

22. my motivation to do physical activities

1

2

3

4

5

23. my motivation to participate in social activities

1

2

3

4

5

24. my muscles ache when I am fatigued

1

2

3

4

5

25. long periods of inactivity increase my fatigue

1

2

3

4

5

26. stress increases my fatigue

1

2

3

4

5

27. fatigue increases my stress

1

2

3

4

5

28. I pace my physical activities to manage my fatigue

1

2

3

4

5

29. I think about fatigue when I plan my day

1

2

3

4

5

30. I limit my physical activity to manage my fatigue

1

2

3

4

5

31. I stop and rest during activity to manage my fatigue

1

2

3

4

5

In addition,

© Brunton, 2014. “Copy Freely – Do NOT Change”

Appendix A
Additional Questions:
32. Does your level of fatigue change depending on the time of day?
Yes

(If yes, please answer question 32b)

No

32b. What time of day is your fatigue the worst?
Early Morning

Mid-morning

1

2

Noon

Late afternoon

Evening

3

4

5

33. Does your level of fatigue change depending on the day of the week?
Yes

(If yes, please answer question 33b)

No

33b. On which day of the week are you most fatigued?
Monday

Tuesday

1

2

Wednesday
3

Thursday

Friday

Saturday

5

6

4

34. What factors are responsible for or contribute to your fatigue?

35. What do you do to reduce or manage your fatigue?

36. What else could you do to reduce or manage your fatigue?

37. What could other people do to help reduce your fatigue?

© Brunton, 2014. “Copy Freely – Do NOT Change”
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Table 1 - Participant Characteristics and Demographic Information of the Sample
Characteristic
Total (n=130)
n (%)
Sex*
Male
61 (47%)
Female
68 (53%)
Age

Mean, years (SD)
Median
Range

18.9 (4.5)
17
14-31

GMFCS Level

I
II
III
IV
V

34 (27%)
39 (32%)
21 (17%)
18 (14%)
12 (10%)

Distribution of Involvement

Monoplegia
6 (5%)
Hemiplegia
31 (25%)
Diplegia
44 (35%)
Triplegia
11 (9%)
Quadriplegia
34 (26%)
GMFCS= Gross Motor Function Classification System; Note: *one participant did not
report their sex; six participants did not report GMFCS level; four participants
did not report distribution of involvement.

Table 2 – Fatigue Impact and Severity Self-Assessment Item Factor Loadings
Item
Fatigue interferes with my ability to do
things on my own
I use adaptive equipment to manage my
fatigue
Fatigue interferes with my ability to take
care of myself
Fatigue interferes with my ability to move
around indoors
Fatigue interferes with my ability to get
outside of my house
I have had to reduce my work
responsibilities outside my home because
of fatigue
Fatigue interferes with my ability to move
around in my community
Rate your average level of fatigue for the
past week
I have had to reduce my responsibilities at
home because of fatigue
Rate your level of fatigue on the day
within the last week that you felt the least
fatigued
On average, how much of the day do you
feel fatigued
Rate your level of fatigue on the day
within the last week that you felt most
fatigued
Fatigue interferes with my general
everyday activities
Fatigue interferes with my ability to start
things
For how many days last week did you feel
fatigued at least part of the day
Fatigue interferes with my ability to finish
things
Fatigue interferes with my participation in
social activities
Fatigue interferes with the length of time I
can be physically active
I limit my physical activity to manage my
fatigue
My motivation to do physical activities
I stop and rest during activity to manage
my fatigue
Fatigue interferes with my balance and
coordination

Rotated Factor Loadings
Factor 1 – Impact of Fatigue Factor 2 – Management
on Daily Living
and Activity Modification
.77
.03
.77

-.27

.73

-.07

.73

.12

.70

.10

.70

.06

.70

.17

.70

.18

.69

.08

.68

-.09

.68

.07

.64

.17

.57

.31

.50

.18

.50

.24

.46

.36

.43

.41

.12

.72

-.05

.71

.05
-.01

.70
.68

.03

.68

Table 3 - Summary of Fatigue Scores for Known Groups Validity Testing
Construct
Subgroups
FISSA Score
FISSA Impact FISSA
Median,
Score Median Management
(Range)
(Range)
Score Median
(Range)
Functional
GMFCS Level I 69 (30, 122)
31 (16, 62)
39 (14, 60)
Level
(n=35)
GMFCS Level II 96 (37, 147)
49 (20, 78)
49 (14, 66)
and III (n=63)
GMFCS Level
106 (38, 146) 57 (21, 83)
51 (17, 61)
IV and V
(n=39)
Pain Severity
Low Pain
75 (30, 146)
38 (16, 83)
42 (14, 64)
th
Severity ≤ 50
percentile
(n=84)
High Pain
109 (39, 157) 58 (20, 87)
53 (19, 70)
st
Severity ≥ 51
percentile
(n=60)
Pain Impact
Low Pain
75 (30, 146)
35.5 (16, 83)
41.5 (14, 64)
Impact ≤ 50th
percentile
(n=79)
High Pain
108 (39, 157) 56 (19, 70)
53 (19, 70)
Impact
Severity ≥ 51st
percentile
(n=63)
GMFCS= Gross Motor Function Classification System

Figure 1 – Breakdown of Inclusion and Exclusion of Returned Surveys

